CFDE Data Portal | Search PPIEL

	Label	Description
	PPIEL Gene (Entity type)	ENSG00000291129 - peptidylprolyl isomerase E like (pseudogene)
	PPIEL associations Collection (Entity type)	Associations for PPIEL_associations
	PPIEL associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE220806 progesterone fibroblast 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE226249 pirfenidone HL 0 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE113655 phenol 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE196343 metformin 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE197555 trametinib A-549 NCI-H460 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE77108 saha 5 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE158834 ADIPOR2 knockout HEK293 12 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS

PPIEL

ENSG00000291129 - peptidylprolyl isomerase E like (pseudogene)

PPIEL associations

Associations for PPIEL_associations

PPIEL associations.tsv

A file from IDG as part of the Harmonizome project

GSE220806 progesterone fibroblast 1 v 3 human dn

A Gene Set from LINCS

GSE226249 pirfenidone HL 0 v 7 human dn

A Gene Set from LINCS

GSE113655 phenol 1 v 2 human dn

A Gene Set from LINCS

GSE196343 metformin 1 v 0 human dn

A Gene Set from LINCS

GSE197555 trametinib A-549 NCI-H460 1 v 2 human dn

A Gene Set from LINCS

GSE77108 saha 5 v 2 human up

A Gene Set from LINCS

GSE158834 ADIPOR2 knockout HEK293 12 v 5 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.